Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic Impact

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Sep 4

PMID 26336064

Citations 15

Authors

Zhen Su

Yan-Ping Mao

Pu-Yun OuYang

Jie Tang

Fang-Yun Xie

Affiliations

Soon will be listed here.

Abstract

Background: This study aimed to evaluate initial hyperleukocytosis and neutrophilia as prognostic indicators in patients with nasopharyngeal carcinoma.

Methods: A retrospective analysis of 5,854 patients identified from a cohort of 6,035 patients diagnosed with nasopharyngeal carcinoma was performed with initial hyperleukocytosis and neutrophilia analyzed as prognostic factors. Multivariate Cox proportional hazards analyses were applied.

Results: Hyperleukocytosis was observed in 508 patients (8.7%). Multivariate analysis showed that initial hyperleukocytosis was an independent predictor of death (HR 1.40, 95%CI 1.15-1.70, p = 0.001), progression (HR 1.25, 95%CI 1.06-1.47, p = 0.007) and, marginally, distant metastasis (HR 1.21, 95%CI 0.97-1.52, p = 0.088). Neutrophilia was also an independent predictor of death (HR 1.46, 95%CI 1.18-1.81, p = 0.001), progression (HR 1.31, 95%CI 1.10-1.56, p = 0.003), and distant metastasis (HR 1.29, 95%CI 1.02-1.65, p = 0.036), after adjusting for prognostic factors and excluding hyperleukocytosis.

Conclusion: Initial hyperleukocytosis and neutrophilia were independent, poor prognostic factors and may be convenient and useful biological markers for survival of patients with nasopharyngeal carcinoma.

Citing Articles

Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy.

Aonta P, Jaiyangyeun P, Theerapan W, Srisampan S, Wongsali C, Kovitvadhi A Animals (Basel). 2025; 14(24.

PMID: 39765477 PMC: 11672515. DOI: 10.3390/ani14243573.

Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings.

Gilmore N, Li Y, Seplaki C, Sohn M, Yang Y, Li C Oncologist. 2024; 30(2).

PMID: 39177095 PMC: 11881059. DOI: 10.1093/oncolo/oyae212.

An Annual Symposium on Disparities in Milwaukee, WI, with a 2023 Focus on Older Adults with Cancer.

Kamaraju S, McKoy J, Williams G, Gilmore N, Minami C, Bylow K Curr Oncol Rep. 2024; 26(8):855-864.

PMID: 38801612 PMC: 11300154. DOI: 10.1007/s11912-024-01525-6.

Pan‑immune‑inflammation value as a novel prognostic biomarker in nasopharyngeal carcinoma.

Su Z, Tang J, He Y, Zeng W, Yu Q, Cao X Oncol Lett. 2024; 27(6):252.

PMID: 38646495 PMC: 11027095. DOI: 10.3892/ol.2024.14385.

Epigenetic and inflammatory markers in older adults with cancer: A Young International Society of Geriatric Oncology narrative review.

Gilmore N, Loh K, Liposits G, Arora S, Vertino P, Janelsins M J Geriatr Oncol. 2023; 15(1):101655.

PMID: 37931584 PMC: 10841884. DOI: 10.1016/j.jgo.2023.101655.

References

Qiu M, Xu R, Ruan D, Li Z, Luo H, Teng K . Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol. 2010; 31(6):633-41. DOI: 10.1007/s13277-010-0079-8. View

Shin J, Lim Y, Song Y, So B, Park J, Fang C . Granulocyte-colony stimulating factor reduces cardiomyocyte apoptosis and ameliorates diastolic dysfunction in Otsuka Long-Evans Tokushima Fatty rats. Cardiovasc Drugs Ther. 2014; 28(3):211-20. DOI: 10.1007/s10557-014-6519-8. View

Dumitru C, Gholaman H, Trellakis S, Bruderek K, Dominas N, Gu X . Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer. 2011; 129(4):859-69. DOI: 10.1002/ijc.25991. View

cerny J, Rosmarin A . Why does my patient have leukocytosis?. Hematol Oncol Clin North Am. 2012; 26(2):303-19, viii. DOI: 10.1016/j.hoc.2012.01.001. View

Worley Jr M, Nitschmann C, Shoni M, Vitonis A, Rauh-Hain J, Feltmate C . The significance of preoperative leukocytosis in endometrial carcinoma. Gynecol Oncol. 2012; 125(3):561-5. DOI: 10.1016/j.ygyno.2012.03.043. View

Cetin B, Kaplan M, Berk V, Ozturk S, Benekli M, Isikdogan A . Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents. Asian Pac J Cancer Prev. 2012; 13(3):1059-63. DOI: 10.7314/apjcp.2012.13.3.1059. View

Adham M, Kurniawan A, Muhtadi A, Roezin A, Hermani B, Gondhowiardjo S . Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 2012; 31(4):185-96. PMC: 3777476. DOI: 10.5732/cjc.011.10328. View

Chen L, Mao Y, Xie F, Liu L, Sun Y, Tian L . The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China. Radiother Oncol. 2011; 104(3):331-7. DOI: 10.1016/j.radonc.2011.10.009. View

Peng G, Wang T, Yang K, Zhang S, Zhang T, Li Q . A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012; 104(3):286-93. DOI: 10.1016/j.radonc.2012.08.013. View

10.

Mabuchi S, Matsumoto Y, Hamasaki T, Kawano M, Hisamatsu T, Mutch D . Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer. Int J Gynecol Cancer. 2012; 22(9):1545-51. DOI: 10.1097/IGC.0b013e31826ea0eb. View

11.

He J, Shen G, Ren Z, Qin H, Cui C, Zhang Y . Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma. Head Neck. 2012; 34(12):1769-76. DOI: 10.1002/hed.22008. View

12.

Worley Jr M, Nitschmann C, Shoni M, Rauh-Hain J, Williams K, Feltmate C . Preoperative leukocytosis imposes an increased risk of recurrence and death among patients with nonendometrioid endometrial carcinoma. Int J Gynecol Cancer. 2013; 23(2):312-7. DOI: 10.1097/IGC.0b013e31827da21b. View

13.

Hirai K, Kumakiri M, Fujieda S, SUNAGA H, Lao L, Imamura Y . Expression of granulocyte colony-stimulating factor and its receptor in epithelial skin tumors. J Dermatol Sci. 2001; 25(3):179-88. DOI: 10.1016/s0923-1811(00)00131-6. View

14.

Luomaranta A, Leminen A, Loukovaara M . Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology. Gynecol Oncol. 2013; 129(1):28-32. DOI: 10.1016/j.ygyno.2013.01.008. View

15.

Donskov F . Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013; 23(3):200-7. DOI: 10.1016/j.semcancer.2013.02.001. View

16.

Brandau S . The dichotomy of neutrophil granulocytes in cancer. Semin Cancer Biol. 2013; 23(3):139-40. DOI: 10.1016/j.semcancer.2013.02.008. View

17.

Brandau S, Moses K, Lang S . The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?. Semin Cancer Biol. 2013; 23(3):171-82. DOI: 10.1016/j.semcancer.2013.02.007. View

18.

Chen Y, Chen I, Lin I, Kao S . Prognostic value of hypercalcaemia and leucocytosis in resected oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2014; 52(5):425-31. DOI: 10.1016/j.bjoms.2014.02.014. View

19.

Ma J, Liu L, Tang L, Zong J, Lin A, Lu T . Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res. 2007; 13(5):1445-52. DOI: 10.1158/1078-0432.CCR-06-2059. View

20.

Wu F, Wang R, Lu H, Wei B, Feng G, Li G . Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study. Radiother Oncol. 2014; 112(1):106-11. DOI: 10.1016/j.radonc.2014.05.005. View